- Testing different ways to implement home-based testing for SARS-CoV-2 in American Indian and Hispanic/Latino communities.
- Developing community-driven protocols and materials that be used to increase testing among American Indian and Hispanic communities nationally
Early in 2020, the NIH launched the Rapid Acceleration of Diagnostics (RADxSM) initiative to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.
Led by Montana State University, in collaboration with Matthew Thompson and other colleagues at the UW, this project will help to tackle the disproportionate impact of the COVID19 pandemic in people who identify as American Indian or Hispanic/Latino. These communities already face significant disparities in health care access, which has been exacerbated by the COVID-19 pandemic.
This project will test the most acceptable and effective ways to use home-based testing for SARS-CoV-2 in these communities, examining the cultural, socio-behavioral and economic barriers to SARS-CoV-2 testing, and evaluate the implementation of home self-testing in a randomized trial.
WHAT IS THE TECHNOLOGY’S POTENTIAL IMPACT ON PRIMARY CARE?
Home testing is becoming widely used for SARS-CoV-2, as well as other infections such as influenza. Home-based or self-testing has the potential to improve access to needed tests, but relies on tests being suitable in terms of their accuracy and acceptability. Primary care providers are likely the first point of contact for most individuals using home tests, it is therefore vital that primary care
WHAT IS PCI-Lab Doing?
We are partners on this NIH study, and contributing to the point of care COVID-19 tests that will be used in the trial, and analysis of trial results. In addition we will be helping to develop the materials that individuals need to be able to use these types of tests.